BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18849196)

  • 1. Recombinant Mycobacterium bovis BCG vector system expressing SIV Gag protein stably and persistently induces antigen-specific humoral immune response concomitant with IFN gamma response, even at three years after immunization.
    Kawahara M
    Clin Immunol; 2008 Dec; 129(3):492-8. PubMed ID: 18849196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.
    Leung NJ; Aldovini A; Young R; Jarvis MA; Smith JM; Meyer D; Anderson DE; Carlos MP; Gardner MB; Torres JV
    Virology; 2000 Mar; 268(1):94-103. PubMed ID: 10683331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cocktail of Mycobacterium bovis BCG recombinants expressing the SIV Nef, Env, and Gag antigens induces antibody and cytotoxic responses in mice vaccinated by different mucosal routes.
    Lagranderie M; Winter N; Balazuc AM; Gicquel B; Gheorghiu M
    AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1625-33. PubMed ID: 9870315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins.
    Mills KH; Page M; Chan WL; Kitchin P; Stott EJ; Taffs F; Jones W; Rose J; Ling C; Silvera P
    J Med Primatol; 1992; 21(2-3):50-8. PubMed ID: 1433267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-induced CD4+ T cells against the simian immunodeficiency virus gag protein. Epitope specificity and relevance to protective immunity.
    Mills KH; Barnard AL; Williams M; Page M; Ling C; Stott EJ; Silvera P; Taffs F; Kingsman AS; Adams SE
    J Immunol; 1991 Nov; 147(10):3560-7. PubMed ID: 1719081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines.
    Aldovini A; Young RA
    Nature; 1991 Jun; 351(6326):479-82. PubMed ID: 2046750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice.
    Lagranderie M; Balazuc AM; Gicquel B; Gheorghiu M
    J Virol; 1997 Mar; 71(3):2303-9. PubMed ID: 9032366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants.
    Zhao J; Lou Y; Pinczewski J; Malkevitch N; Aldrich K; Kalyanaraman VS; Venzon D; Peng B; Patterson LJ; Edghill-Smith Y; Woodward R; Pavlakis GN; Robert-Guroff M
    Vaccine; 2003 Sep; 21(25-26):4022-35. PubMed ID: 12922139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Mycobacterium bovis BCG producing the N-terminal half of SIVmac251 Env antigen induces neutralizing antibodies and cytotoxic T lymphocyte responses in mice and guinea pigs.
    Lim EM; Lagranderie M; Le Grand R; Rauzier J; Gheorghiu M; Gicquel B; Winter N
    AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1573-81. PubMed ID: 9430249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined intrarectal/intradermal inoculation of recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) induces enhanced immune responses against the inserted HIV-1 V3 antigen.
    Kawahara M; Matsuo K; Nakasone T; Hiroi T; Kiyono H; Matsumoto S; Yamada T; Yamamoto N; Honda M
    Vaccine; 2002 Dec; 21(3-4):158-66. PubMed ID: 12450689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes.
    Klavinskis LS; Bergmeier LA; Gao L; Mitchell E; Ward RG; Layton G; Brookes R; Meyers NJ; Lehner T
    J Immunol; 1996 Sep; 157(6):2521-7. PubMed ID: 8805653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with recombinant BCG-SIV elicits SIV-specific cytotoxic T lymphocytes in rhesus monkeys.
    Yasutomi Y; Koenig S; Haun SS; Stover CK; Jackson RK; Conard P; Conley AJ; Emini EA; Fuerst TR; Letvin NL
    J Immunol; 1993 Apr; 150(7):3101-7. PubMed ID: 8454878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral immunization with simian immunodeficiency virus p55gag and cholera toxin elicits both mucosal IgA and systemic IgG immune responses in nonhuman primates.
    Kubota M; Miller CJ; Imaoka K; Kawabata S; Fujihashi K; McGhee JR; Kiyono H
    J Immunol; 1997 Jun; 158(11):5321-9. PubMed ID: 9164952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of protective efficacy of recombinant subunit vaccines against simian immunodeficiency virus infection of macaques.
    Hu SL; Abrams K; Misher L; Stallard V; Moran P; Zarling JM; Langlois AJ; Kuller L; Morton WR; Benveniste RE
    J Med Primatol; 1992; 21(2-3):119-25. PubMed ID: 1433262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate.
    Kantor J; Irvine K; Abrams S; Snoy P; Olsen R; Greiner J; Kaufman H; Eggensperger D; Schlom J
    Cancer Res; 1992 Dec; 52(24):6917-25. PubMed ID: 1458480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cell-mediated immune responses of d/d histocompatible pigs against classical swine fever (CSF) virus.
    Piriou L; Chevallier S; Hutet E; Charley B; Le Potier MF; Albina E
    Vet Res; 2003; 34(4):389-404. PubMed ID: 12911856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cellular immune responses to SIV Gag by immunization with influenza and vaccinia virus recombinants.
    Nakaya Y; Zheng H; García-Sastre A
    Vaccine; 2003 May; 21(17-18):2097-106. PubMed ID: 12706700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal Th1- versus Th2-type responses for antibody- or cell-mediated immunity to simian immunodeficiency virus in rhesus macaques.
    McGhee JR; Kiyono H; Kubota M; Kawabata S; Miller CJ; Lehner T; Imaoka K; Fujihashi K
    J Infect Dis; 1999 May; 179 Suppl 3():S480-4. PubMed ID: 10099124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates.
    Lehner T; Bergmeier LA; Tao L; Panagiotidi C; Klavinskis LS; Hussain L; Ward RG; Meyers N; Adams SE; Gearing AJ
    J Immunol; 1994 Aug; 153(4):1858-68. PubMed ID: 7519218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.